본문 바로가기
KERD
논문KCI 등재

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

Wai-Kay Seto|Man-Fung Yuen|Ran Xu Zhu|Ching-Lung Lai
거트앤리버 소화기연관학회협의회|2016.05|Gut and Liver|제10권 제3호|pp. 332-339

1

조회

0

다운로드

11

인용

0

참고문헌

키워드

IncidenceMortalityPrevalenceCarcinomahepatocellularLiver neoplasms

초록

Hepatocellular carcinoma (HCC) is the predominant primary liver cancer in many countries and is the third most common cause of cancer-related death in the Asia-Pacific region. The incidence of HCC is higher in men and in those over 40 years old. In the Asia-Pacific region, chronic hepatitis B virus and hepatitis C virus infections are the main etiological agents; in particular, chronic hepatitis B infection (CHB) is still the major cause in all Asia-Pacific countries except for Japan. Over the past two decades, the incidence of HCC has remained stable in countries in the region except for Singapore and Hong Kong, where the incidence for both sexes is currently decreasing. Chronic hepatitis C infection (CHC) is an important cause of HCC in Japan, representing 70% of HCCs. Over the past several decades, the prevalence of CHC has been increasing in many Asia-Pacific countries, including Australia, New Zealand, and India. Despite advancements in treatment, HCC is still an important health problem because of the associated substantial mortality. An effective surveillance program could offer early diagnosis and hence better treatment options. Antiviral treatment for both CHB and CHC is effective in reducing the incidence of HCC.

Abstract

Hepatocellular carcinoma (HCC) is the predominant primary liver cancer in many countries and is the third most common cause of cancer-related death in the Asia-Pacific region. The incidence of HCC is higher in men and in those over 40 years old. In the Asia-Pacific region, chronic hepatitis B virus and hepatitis C virus infections are the main etiological agents; in particular, chronic hepatitis B infection (CHB) is still the major cause in all Asia-Pacific countries except for Japan. Over the past two decades, the incidence of HCC has remained stable in countries in the region except for Singapore and Hong Kong, where the incidence for both sexes is currently decreasing. Chronic hepatitis C infection (CHC) is an important cause of HCC in Japan, representing 70% of HCCs. Over the past several decades, the prevalence of CHC has been increasing in many Asia-Pacific countries, including Australia, New Zealand, and India. Despite advancements in treatment, HCC is still an important health problem because of the associated substantial mortality. An effective surveillance program could offer early diagnosis and hence better treatment options. Antiviral treatment for both CHB and CHC is effective in reducing the incidence of HCC.

참고문헌 (68)

  1. Boyle P, "World cancer report 2008" (2008), IARC Press
  2. Ahmed F, "National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003", Prev Chronic Dis, 5, pp.A74~ (2008)
  3. Kew MC, "Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma", Pathol Biol, 58, pp.273~277 (2010)
  4. Lai CL, "Viral hepatitis B", Lancet, 362, pp.2089~2094 (2003)
  5. Nordenstedt H, "The changing pattern of epidemiology in hepatocellular carcinoma", Dig Liver Dis, 42(3), pp.S206~S214 (2010)
  6. Parkin DM, "Global cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
  7. Yang JD, "Hepatocellular carcinoma: a global view", Nat Rev Gastroenterol Hepatol, 7, pp.448~458 (2010)
  8. Gomaa AI, "Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis", World J Gastroenterol, 14, pp.4300~4308 (2008)
  9. Di Bisceglie AM, "Epidemiology and clinical presentation of hepatocellular carcinoma", J Vasc Interv Radiol, 13(9 Pt 2), pp.S169~S171 (2002)
  10. El-Serag HB, "Hepatocellular carcinoma: epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
  11. Poon D, "Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009", Lancet Oncol, 10, pp.1111~1118 (2009)
  12. Montalto G, "Epidemiology, risk factors, and natural history of hepatocellular carcinoma", Ann N Y Acad Sci, 963, pp.13~20 (2002)
  13. Blumberg BS, "The relation of infection with the hepatitis B agent to primary hepatic carcinoma", Am J Pathol, 81, pp.669~682 (1975)
  14. Block TM, "Molecular viral oncology of hepatocellular carcinoma.", Oncogene, 22, pp.5093~5107 (2003)
  15. McGlynn KA, "Epidemiology and natural history of hepatocellular carcinoma.", Best Pract Res Clin Gastroenterol, 19, pp.3~23 (2005)
  16. Nguyen VT, "Estimates and projections of hepatitis B-related hepatocellular carcinoma in Aus-tralia among people born in Asia-Pacific countries", J Gastroenterol Hepatol, 23, pp.922~929 (2008)
  17. Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", JAMA, 295, pp.65~73 (2006)
  18. Chen CJ, "Hepatitis B virus DNA levels and outcomes in chronic hepatitis B", Hepatology, 49(5), pp.S72~S84 (2009)
  19. Chen JD, "Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death", Gastroenterology, 138, pp.1747~1754 (2010)
  20. Han YF, "Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma", World J Gastroenterol, 17, pp.4258~4270 (2011)
  21. Tseng TC, "Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers", J Infect Dis, 208, pp.584~593 (2013)
  22. Geier A, "Hepatitis B e antigen and the risk of hepatocellular carcinoma", N Engl J Med, 347, pp.1721~1722 (2002)
  23. Sunbul M, "Hepatitis B virus genotypes: global distribution and clinical importance", World J Gastroenterol, 20, pp.5427~5434 (2014)
  24. Chan HL, "Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma", Gut, 53, pp.1494~1498 (2004)
  25. Tseng TC, "High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load", Gastroenterology, 142(e3), pp.1140~1149 (2012)
  26. Lu SN, "A case-control study of primary hepatocellular carcinoma in Taiwan", Cancer, 62, pp.2051~2055 (1988)
  27. Fasani P, "High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors", Hepatology, 29, pp.1704~1707 (1999)
  28. Parkin DM, "The global health burden of infection-associated cancers in the year 2002", Int J Cancer, 118, pp.3030~3044 (2006)
  29. But DY, "Natural history of hepatitis-related hepatocellular carcinoma", World J Gastroenterol, 14, pp.1652~1656 (2008)
  30. Donato F, "Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women", Am J Epidemiol, 155, pp.323~331 (2002)
  31. Colombo M, "Hepatocellular carcinoma in Italian patients with cirrhosis", N Engl J Med, 325, pp.675~680 (1991)
  32. Zhang YJ, "Silencing of glutathione Stransferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma", Cancer Lett, 221, pp.135~143 (2005)
  33. Ghebranious N, "Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice", Hepatology, 27, pp.383~391 (1998)
  34. Wang P, "Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and metaanalysis", Diabetes Metab Res Rev, 28, pp.109~122 (2012)
  35. Wang C, "Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies", Int J Cancer, 130, pp.1639~1648 (2012)
  36. Davila JA, "Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study", Gut, 54, pp.533~539 (2005)
  37. Ohishi W, "Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study", Cancer Epidemiol Biomarkers Prev, 17, pp.846~854 (2008)
  38. Law MG, "Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality", Med J Aust, 173, pp.403~405 (2000)
  39. Kemp W, "Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease", J Gastroenterol Hepatol, 20, pp.873~881 (2005)
  40. Walter SR, "Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C", J Gastroenterol Hepatol, 26, pp.1757~1764 (2011)
  41. O’Sullivan BG, "Estimates of chronic hepatitis B virus infection in Australia, 2000", Aust N Z J Public Health, 28, pp.212~216 (2004)
  42. Amin J, "Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study", Aust N Z J Public Health, 31, pp.475~482 (2007)
  43. Tanaka M, "Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures", J Epidemiol, 21, pp.401~416 (2011)
  44. Fan JH, "Attributable causes of liver cancer mortality and incidence in china", Asian Pac J Cancer Prev, 14, pp.7251~7256 (2013)
  45. Zhou X, "Changing prognosis of primary liver cancer: some aspects to improve long-term survival", Zhonghua Zhong Liu Za Zhi, 18, pp.211~213 (1996)
  46. Chen W, "Report of cancer incidence and mortality in China, 2010", Ann Transl Med, 2, pp.61~ (2014)
  47. Lin J, "A study on aetiological factors of primary hepato-carcinoma in Tianjin China", Zhonghua Liu Xing Bing Xue Za Zhi, 12, pp.346~349 (1991)
  48. Chen JG, "Trends in the incidence of cancer in Qidong, China, 1978-2002", Int J Cancer, 119, pp.1447~1454 (2006)
  49. "Overview of Hong Kong cancer statistics" (2015)[URL]
  50. Yuen MF, "Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience", Hepatology, 31, pp.330~335 (2000)
  51. Yeole BB, "Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India", Asian Pac J Cancer Prev, 9, pp.97~100 (2008)
  52. Kumar M, "Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India", J Gastroenterol Hepatol, 22, pp.1104~1111 (2007)
  53. Tanaka H, "Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003", Ann Intern Med, 148, pp.820~826 (2008)
  54. Umemura T, "Epidemiology of hepatocellular carcinoma in Japan", J Gastroenterol, 44(19), pp.102~107 (2009)
  55. Park JW, "Hepatocellular carcinoma in Korea: introduction and overview", Korean J Gastroenterol, 45, pp.217~226 (2005)
  56. Best health outcomes for Pacific peoples: practice implications, "Medical Council of New Zealand", Medical Council of New Zealand, ~ (2010)
  57. Meredith I, "Cancer in Pacific people in New Zealand", Cancer Causes Control, 23, pp.1173~1184 (2012)
  58. Fernandes ML, "Trends in the incidence of hepatocellular carcinoma in Singapore 1968-2002", Hepatology, 46(4 Suppl 1), pp.418A~ (2007)
  59. Lu SN, "Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan", Int J Cancer, 119, pp.1946~1952 (2006)
  60. Chang MH, "Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group", N Engl J Med, 336, pp.1855~1859 (1997)
  61. Yuen MF, "Hepatocellular carcinoma in the Asia pacific region", J Gastroenterol Hepatol, 24, pp.346~353 (2009)
  62. Klevens RM, "Evolving epidemiology of hepatitis C virus in the United States", Clin Infect Dis, 55(1), pp.S3~S9 (2012)
  63. Schweitzer A, "Estimations of worldwide prevalence of chronic hepatitis B virus infection:a systematic review of data published between 1965 and 2013", Lancet, 386, pp.1546~1555 (2015)
  64. Lai CL, "Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong", Cancer, 47, pp.2746~2755 (1981)
  65. Lai CL, "Hepatocellular carcinoma in Chinese males and females: possible causes for the male predominance", Cancer, 60, pp.1107~1110 (1987)
  66. Shiu W, "Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases", Oncology, 47, pp.241~245 (1990)
  67. Leung NW, "Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong?", Cancer, 70, pp.40~44 (1992)
  68. Cheung TK, "Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong", Aliment Pharmacol Ther, 24, pp.573~583 (2006)

관련 논문AI추천

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparisonBo Hyun Kim, Joong-Won Park, Yuri Cho대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatmentAmit G. Singal, Ghassan K. Abou-Alfa, Ju Dong Yang, Neehar D. Parikh, Neil Mehta, Pojsakorn Danpanichkul, Soo Young Hwang, Vatche Agopian대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study김범경, 김승업, 신재일, Ai Koyanagi, Dong Keon Yon, Elena Dragioti, Han Gyeol Lee, Ho Hyeok Chang, Joaquim Radua, Lee Smith, Louis Jacob, Seoyeon Park, Seung Won Lee, Sungchul Choi대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Epidemiology of liver cancer in South Korea김보현, Joong-Won Park대한간학회 · Clinical and Molecular Hepatology2018 · 제24권 제1호Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide populationbased study in hepatitis B virus-endemic areaBo Hyun Kim, Dahhay Lee, Hyunsoon Cho, Kyu-Won Jung, Young-Joo Won대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제2호Risk of hepatitis B virus-related hepatocellular carcinoma development is much higher in Koreans than in Taiwanese김병호, 김정욱, 심재준대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제5호

이 간행물의 다른 논문 (25건)

The Garlic Preparation as an Alternative Way for Gastroprotection: From Bench to ClinicJong-Jae Parkpp. 321-322Helicobacter pylori Eradication, a Gordian Knot for Idiopathic Thrombocytopenic Purpura?김태호, 정대영pp. 323-324Mast Cell May Be the Master Key to Solve the Mystery of Pathogenesis of Irritable Bowel SyndromeHyuk Yoonpp. 325-326Patients’ Preference for a Specific Anti-Tumor Necrosis Factor Agent: Korea versus WesternHyungil Seo, Byong Duk Yepp. 327-329The Mental Health State of Quiescent Inflammatory Bowel Disease PatientsYoon Tae Jeen, Sung Chul Parkpp. 330-331
원문 보기